-+ 0.00%
-+ 0.00%
-+ 0.00%

GeneDx Holdings Narrows FY2025 Sales Guidance from $425.000M-$428.000M to $427.000M vs $426.934M Est

Benzinga·01/12/2026 12:54:08
Listen to the news
GeneDx Holdings (NASDAQ:WGS) narrows FY2025 sales outlook from $425.000 million-$428.000 million to $427.000 million vs $426.934 million estimate.